JUPITER, Fla.--(BUSINESS WIRE)--BioCurity, a preclinical biotech company focused on developing novel mechanism-based nanoparticle drugs designed to transform radiation therapy for cancer patients worldwide, today announced an abstract regarding the Company’s proprietary technology on cerium oxide nanoparticle was accepted for a poster presentation at the American College of Radiation Oncology (ACRO) 2022 Summit, taking place March 9 - 12, 2022 at the Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida.